Nautilus Biotechnology (NAUT) Stock Price Target 2026

The average analyst price target for Nautilus Biotechnology is $3.25, 37.1% above the current price. Of 5 analysts, 3 rate it Buy, 1 Hold and 1 Sell. Targets range from $1.75 to $4. The latest change came on Sep 29, 2026, when Roth Capital initiated coverage of Nautilus Biotechnology with a Buy rating and a $3.50 price target.